Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Plos One|June 17, 2016
Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III TrialZeinab Hamidou, Benoist Chibaudel, Mohamed Hebbar, et al.
Cancer Research|September 5, 2002
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapySamir Attoub, Christine Rivat, Sylvie Rodrigues, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
Cetuximab efficacy in patients treated routinely in university hospitalsJean-Baptiste Bachet, Pauline Afchain, Christophe Fermanian, et al.
The Oncologist|August 24, 2011
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR studyBenoist Chibaudel, Franck Bonnetain, Christophe Tournigand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studiesFlorence Huguet, Thierry André, Pascal Hammel, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR studyMohamed Hebbar, Benoist Chibaudel, Thierry André, et al.
Cancer|October 30, 2007
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 studyArié Figer, Nathalie Perez-Staub, Elisabeth Carola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II studyJulien Taïeb, Pascal Artru, François Paye, et al.
Surgery|December 17, 2008
Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?Frédérique Maire, Pascal Hammel, Reza Kianmanesh, et al.
Surgical Endoscopy|January 24, 2019
After laparoscopic liver resection for colorectal liver metastases, age does not influence morbi-mortalityAlban Zarzavadjian Le Bian, Nicolas Tabchouri, Mostefa Bennamoun, et al.
Pageof 14